Variant report
Variant | nsv1025276 |
---|---|
Chromosome Location | chr6:55349638-55374178 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs532123713 | chr6:55352406-55352407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558405179 | chr6:55352419-55352420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551847712 | chr6:55352566-55352567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6459081 | chr6:55352586-55352587 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs372528366 | chr6:55352595-55352596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531924977 | chr6:55352625-55352626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550253693 | chr6:55352630-55352631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558583289 | chr6:55352644-55352645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187494113 | chr6:55352660-55352661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567966861 | chr6:55352674-55352675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536527774 | chr6:55352695-55352696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192934530 | chr6:55352714-55352715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184572596 | chr6:55352755-55352756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370544838 | chr6:55352758-55352759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs74916287 | chr6:55352783-55352784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546378927 | chr6:55352814-55352815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76891393 | chr6:55352859-55352860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575600784 | chr6:55352891-55352892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544417647 | chr6:55352912-55352913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554453167 | chr6:55352940-55352941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116426588 | chr6:55352947-55352948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111329460 | chr6:55352960-55352961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7756150 | chr6:55353017-55353018 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs7756162 | chr6:55353039-55353040 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs545349204 | chr6:55353057-55353058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9475313 | chr6:55353069-55353070 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs531276837 | chr6:55353076-55353077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188260373 | chr6:55353115-55353116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7756201 | chr6:55353136-55353137 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs10456714 | chr6:55353154-55353155 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs144842031 | chr6:55353170-55353171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9296784 | chr6:55353233-55353234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147936840 | chr6:55353242-55353243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs192263191 | chr6:55353244-55353245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569348969 | chr6:55353268-55353269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537932495 | chr6:55353293-55353294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554795821 | chr6:55353299-55353300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574539101 | chr6:55353313-55353314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61420782 | chr6:55353316-55353317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9475314 | chr6:55353353-55353354 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs75451364 | chr6:55353375-55353376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141732043 | chr6:55353385-55353386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562332271 | chr6:55353442-55353443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567224855 | chr6:55353454-55353455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575250525 | chr6:55353475-55353476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184282278 | chr6:55353540-55353541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189439372 | chr6:55353565-55353566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs371862428 | chr6:55353576-55353577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs62407071 | chr6:55353585-55353586 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs547168804 | chr6:55353597-55353598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 22581003 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:55352400-55355200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
2 | chr6:55358000-55358200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr6:55358000-55358200 | Enhancers | NHEK | skin |
4 | chr6:55358200-55359200 | Weak transcription | NHEK | skin |
5 | chr6:55358800-55359000 | Bivalent/Poised TSS | Fetal Muscle Trunk | muscle |
6 | chr6:55359000-55359400 | Enhancers | Colon Smooth Muscle | Colon |
7 | chr6:55359000-55360400 | Enhancers | Fetal Lung | lung |
8 | chr6:55359200-55361400 | Enhancers | NHEK | skin |
9 | chr6:55359200-55361600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr6:55359800-55361600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr6:55359800-55361600 | Enhancers | HMEC | breast |
12 | chr6:55360000-55360400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr6:55360400-55361400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr6:55360600-55361800 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr6:55361200-55361600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr6:55362400-55363000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr6:55362400-55363000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr6:55362400-55363000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr6:55362400-55363000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |